Vered Bisker-Leib - Nov 22, 2022 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Signature
/s/ Vered Bisker-Leib
Stock symbol
CMPX
Transactions as of
Nov 22, 2022
Transactions value $
-$103,708
Form type
4
Date filed
11/25/2022, 03:41 PM
Previous filing
Nov 22, 2022
Next filing
Jan 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMPX Common Stock Sale -$62.6K -14.9K -1.38% $4.19 1.07M Nov 22, 2022 Direct F1, F2
transaction CMPX Common Stock Sale -$41.1K -9.57K -0.89% $4.30 1.06M Nov 23, 2022 Direct F1, F2
transaction CMPX Common Stock Sale -$9 -2 0% $4.36 1.06M Nov 25, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are included in the Reporting Person's award agreement which allows the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction.
F2 The price reported in Column 4 is the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $4.10 to $4.30 per share on November 22, 2022 and $4.15 to $4.43 on November 23, 2022. The reporting person hereby undertakes to provide, upon request, to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, full information regarding the number of shares purchased and prices within the range set forth above.